22 May 2013
Keywords: asta, cetrorelix, enters, phase, iii, trials, nce
Article | 12 August 1996
Asta Medica has completed two dose-ranging clinical trials of its
luteinizing hormone-releasing hormone antagonist Cetrorelix and is now
starting its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 August 1996
© 2013 thepharmaletter.com